Literature DB >> 11113375

Human deficiencies in type 1 cytokine receptors reveal the essential role of type 1 cytokines in immunity to intracellular bacteria.

T H Ottenhoff1, T de Boer, C E Verhagen, F A Verreck, J T van Dissel.   

Abstract

Studies on patients with idiopathic, severe infections due to poorly pathogenic mycobacteria and Salmonella have revealed that many of these patients are unable to produce or respond to interferon-gamma (IFN-gamma). This inability results from causative, deleterious genetic mutations in either one of four different genes in the type 1 cytokine cascade, encoding interleukin-12Rbeta1 (IL-12Rbeta1), IL-12p40, IFN-gammaR1 or IFN-gammaR2. The immunological phenotypes resulting from the seven groups of complete or partial deficiencies in type 1 cytokine (receptor) genes that have been distinguished thus far will be summarized and discussed, and placed in a broader context in relation to disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113375     DOI: 10.1016/s1286-4579(00)01312-5

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  12 in total

1.  Gamma interferon enhances internalization and early nonoxidative killing of Salmonella enterica serovar Typhimurium by human macrophages and modifies cytokine responses.

Authors:  Melita A Gordon; Dominic L Jack; David H Dockrell; Margaret E Lee; Robert C Read
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring.

Authors:  Janine Jason; Lennox K Archibald; Okey C Nwanyanwu; Peter N Kazembe; Julie A Chatt; Elizabeth Norton; Hamish Dobbie; William R Jarvis
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

Authors:  H Martin Vordermeier; Mark A Chambers; Paul J Cockle; Adam O Whelan; Jennifer Simmons; R Glyn Hewinson
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Analysis of the immune response to Mycobacterium avium subsp. paratuberculosis in experimentally infected calves.

Authors:  Hye Cheong Koo; Yong Ho Park; Mary Jo Hamilton; George M Barrington; Christopher J Davies; Jong Bae Kim; John L Dahl; W Ray Waters; William C Davis
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

5.  Infection-triggered regulatory mechanisms override the role of STAT 4 in control of the immune response to influenza virus antigens.

Authors:  A Bot; E Rodrigo; T Wolfe; S Bot; M G Von Herrath
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Interleukin-12 therapy reduces the number of immune cells and pathology in lungs of mice infected with Mycobacterium tuberculosis.

Authors:  Dawn Nolt; JoAnne L Flynn
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

7.  The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection.

Authors:  Jun Sato; Jeffrey Schorey; Victoria A Ploplis; Erijka Haalboom; Liana Krahule; Francis J Castellino
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

Review 8.  Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway.

Authors:  David A Lammas; E De Heer; J D Edgar; V Novelli; A Ben-Smith; R Baretto; P Drysdale; J Binch; C MacLennan; D S Kumararatne; S Panchalingam; T H M Ottenhoff; J-L Casanova; J F Emile
Journal:  Int J Exp Pathol       Date:  2002-02       Impact factor: 1.925

9.  Histamine plays an essential regulatory role in lung inflammation and protective immunity in the acute phase of Mycobacterium tuberculosis infection.

Authors:  D Carlos; C Fremond; A Samarina; V Vasseur; I Maillet; S G Ramos; F Erard; V Quesniaux; H Ohtsu; C L Silva; L H Faccioli; B Ryffel
Journal:  Infect Immun       Date:  2009-10-12       Impact factor: 3.441

10.  Effect of a hydrolyzed mannan- and glucan-rich yeast fraction on performance and health status of newly received feedlot cattle1.

Authors:  Josey R Pukrop; Kristen M Brennan; Bethany J Funnell; Jon P Schoonmaker
Journal:  J Anim Sci       Date:  2018-09-07       Impact factor: 3.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.